The HER Foundation announced that geneticist Dr. Marlena Fejzo, Research Director and Board of Directors, spoke at the first White House Conference on Women’s Health Research. This follows her prestigious honors as…
Read More
Are you as excited as we are about the international Hyperemesis Gravidarum (HG) conference being in the United States for the first time? ICHG 2024 happens every other year, and…
Read More
A new study published in Nature reveals abnormally high levels of the hormone GDF15, and increased sensitivity to it, are the major factors contributing to HG. The most severe form…
Read MoreJoin us November 6-7, 2024, in Ventura, California (near Los Angeles), for ICHG 2024. The conference is days of engaging with top scientists and clinicians specializing in HG management. Bringing together the…
Read More
Be a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read More
Dr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Read More
Be a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read More
The HER Foundation has accomplished a lot in 2022! We are thankful for the support of our donors and community and want to share the highlights that made this HER’s best year yet! This is what 22 years of Helping Generations survive Hyperemesis Gravidarum (HG) looks like.
Read More
The HER Foundation educated me on the website and social media, and I used the HG Care app. When I was scared to take Zofran, they sent me the lastest research. HER understands, and I didn’t feel alone. One day, they will find a cure.
Read More